PDUFA dates April 2021: FDA calendar and catalysts.
0 PDUFA dates fell in April 2021. The FDA calendar also recorded 12 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
PDUFA dates in April 2021
No PDUFA dates are disclosed for this period as of November 16, 2026.
Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months
April 2021: other FDA decisions and filings
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| April 1, 2021 | Praluent (alirocumab) | REGN | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 16, 2021 | Opdivo® (nivolumab) | BMY | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 19, 2021 | Diovan (valsartan) | NVS | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 22, 2021 | Jemperli (dostarlimab-gxly) | GSK | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 23, 2021 | Zynlonta (loncastuximab tesirine-lpyl) | ADCT | FDA approval | — | Approved | openFDA Drugs@FDA |
| April 23, 2021 | Ingrezza Sprinkle (valbenazine tosylate) | NBIX | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 26, 2021 | Skyrizi (risankizumab-rzaa) | ABBV | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 29, 2021 | Daptomycin (daptomycin) | BAX | Complete Response Letter | — | CRL issued | FDA Complete Response Letters |
| April 29, 2021 | Morphine Sulfate (morphine sulfate) | PFE | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 30, 2021 | Farxiga (dapagliflozin) | AZN | Label expansion | — | Approved | openFDA Drugs@FDA |
| April 30, 2021 | Aubagio (teriflunomide) | SNY | Label expansion | — | Approved | openFDA Drugs@FDA |
April 2021: dated readouts
| Date | Drug | Company | Event | Indication | Status | Source |
|---|---|---|---|---|---|---|
| Apr 2021Month disclosed | ISEMBYLD (apitegromab) | SRRK | Topline readout | — | Positive | SEC Form 10-Q |
Questions
What PDUFA dates are in April 2021?
0 PDUFA dates fell in April 2021. The FDA calendar also recorded 12 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.
Can these dates change?
Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.